Skip to search.
 TSX Down 0.03% TSX Ventures Up 0.20%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.51 0.00(0.00%) Jan 13, 4:00PM EST
Prev Close:2.51
Open:2.44
Bid:2.01 x 100
Ask:3.50 x 2000
1y Target Est:6.20
Beta:1.18176
Earnings Date:Mar 6 - Mar 10 (Est.)
Day's Range:2.42 - 2.56
52wk Range:1.88 - 4.38
Volume:444,254
Avg Vol (3m):1,165,160
Market Cap:248.33M
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
RIGL 0.00%248.33M
1 0.00%N/A
AMGN 0.00%116.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.74
Quarterly EPS Est (Dec-16) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel and targeted drug candidates in the therapeutic areas of immunology, oncology, and immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback